Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5

Kathryn J Lindley; C Noel Bairey Merz; Melinda B Davis; Tessa Madden; Ki Park; Natalie A Bello; American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group

doi:10.1016/j.jacc.2021.02.025

Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5

J Am Coll Cardiol. 2021 Apr 13;77(14):1823-1834. doi: 10.1016/j.jacc.2021.02.025.

Authors

Kathryn J Lindley¹, C Noel Bairey Merz², Melinda B Davis³, Tessa Madden⁴, Ki Park⁵, Natalie A Bello⁶; American College of Cardiology Cardiovascular Disease in Women Committee and the Cardio-Obstetrics Work Group

Affiliations

¹ Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: Kathryn.lindley@wustl.edu.
² Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA.
³ Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
⁴ Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA.
⁵ Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
⁶ Department of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

Abstract

The majority of reproductive-age women with cardiovascular disease are sexually active. Early and accurate counseling by the cardiovascular team regarding disease-specific contraceptive safety and effectiveness is imperative to preventing unplanned pregnancies in this high-risk group of patients. This document, the final of a 5-part series, provides evidence-based recommendations regarding contraceptive options for women with, or at high risk for, cardiovascular disease as well as recommendations regarding pregnancy termination for women at excessive cardiovascular mortality risk due to pregnancy.

Keywords: LARC; abortion; contraception; intrauterine device; pregnancy.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Cardiovascular Diseases* / prevention & control
Cardiovascular Diseases* / therapy
Contraception / methods*
Family Planning Services / methods*
Female
Humans
Reproductive Health
Risk Adjustment / methods*

Abstract

Publication types

MeSH terms

Grants and funding